Imugene Limited (IUGNF) Financials

IUGNF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 15.9 million 9.7 million
Dec. 31, 2025 45.2 million 17.2 million
June 30, 2025 55.0 million 25.4 million
Dec. 31, 2024 75.1 million 35.8 million

IUGNF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -13.0 million ?
Dec. 31, 2025 -17.3 million ?
June 30, 2025 -22.2 million 4.2 million
Dec. 31, 2024 -30.7 million ?

IUGNF Net Income

No data available :(

IUGNF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 1.8 million - -
Dec. 31, 2025 9.4 million 16105 16105
June 30, 2025 14.4 million 1.7 million 922287
Dec. 31, 2024 21.0 million 7.3 million 633796

IUGNF Shares Outstanding

No data available :(

IUGNF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 16.1 million 5.6 million -
Dec. 31, 2025 2 16.2 million 7.3 million -
June 30, 2025 2.1 million 10.1 million 5.8 million -
Dec. 31, 2024 6.7 million 19.5 million 11.8 million -

IUGNF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 1.1 million
Dec. 31, 2025 - 3.5 million
June 30, 2025 2.1 million -
Dec. 31, 2024 781689 -

IUGNF

Price: $0.06

52 week price:
0.01
0.31

Earnings Per Share: -0.23 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 12.2 million

Links: